Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
Clinical trial NCT06581640 · RECRUITING
Trial details
- NCT number
- NCT06581640
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-24
- Primary completion
- 2028-12-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.